ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 329 • 2019 ACR/ARP Annual Meeting

    Excessive Alcohol Intake Is Associated with Tophi Formation in Gout Patients

    Qian-Hua Li 1, Chao Deng 1, Li-Juan Yang 1, Jin-Jian Liang 1, Jian-Zi Lin 1, Ying-Qian Mo 1 and Lie Dai1, 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China (People's Republic)

    Background/Purpose: Dietary factors have been recognized as risk factors of hyperuricemia and gout. However, their association with tophi formation remain elusive. The aim of this…
  • Abstract Number: 330 • 2019 ACR/ARP Annual Meeting

    Acute Gout Attacks Among Patients Admitted Due to Heart Failure: Analysis of NIS Database

    Estefania Gauto-Mariotti1, Soumyasri Kambhatla 2, Setri Fugar 3 and AUGUSTINE MANADAN 4, 1Cook County Health, chicago, 2John H. Stroger Hospital of Cook County, Chicago, 3Rush University Medical Center, Chicago, IL, 4Rush University Medical Center, chicago

    Background/Purpose: Acute gout arthropathy is a well-described side effect of aggressive diuresis in patients hospitalized with heart failure.  This study aims to determine the prevalence…
  • Abstract Number: 331 • 2019 ACR/ARP Annual Meeting

    Gout Management in the Medical Community: A Claims-Based Analysis

    N. Lawrence Edwards1, Naomi Schlesinger 2, Sanders Clark 3, Jeremy Paige 4, Theresa Arndt 4 and Peter Lipsky 5, 1Department of Medicine, University of Florida, Gainesville, FL, 2Division of Rheumatology, Department of Medicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, 3HVH Precision Analytics, LLC, Wayne, PA, 4HVH Precision Analytics, Wayne, PA, 5AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Gout is one of the most common inflammatory arthropathies. Despite available urate lowering therapies (ULT), many patients progress to chronic or advanced gout, characterized…
  • Abstract Number: 332 • 2019 ACR/ARP Annual Meeting

    Incident Gout After Renal Transplantation in Gout-naïve Patients: Large Database Analysis

    Brian LaMoreaux1, Megan Francis-Sedlak 1 and Robert Holt 1, 1Horizon Therapeutics plc, Lake Forest, IL

    Background/Purpose: Patients undergoing kidney transplantation are at increased risk for developing hyperuricemia and gout compared to the general population (generally attributed to the frequent use…
  • Abstract Number: 333 • 2019 ACR/ARP Annual Meeting

    Assessing the Relationship Between Gout and Return to Hemodialysis Among U.S. Renal Transplant Patients

    Justin Li1, David Yin 1, Zheng Wang 1, Mark Brigham 1, Brian LaMoreaux 2, Jeffrey Kent 2, Megan Francis-Sedlak 2, Richard Johnson 3, Nandini Hadker 1 and Gavin Miyasato 1, 1Trinity Partners, Waltham, MA, 2Horizon Therapeutics plc, Lake Forest, IL, 3University of Colorado Denver, Aurora, CO

    Background/Purpose: Although gout has been shown to be associated with poor renal outcomes among chronic kidney disease populations, this relationship is not well understood among…
  • Abstract Number: 334 • 2019 ACR/ARP Annual Meeting

    The Role of a ‘Treat-to-Target’ Approach on Long-term Renal Outcomes in Patients with Gout

    Woo-Joong Kim 1, Jung-Soo Song1 and Sang Tae Choi 1, 1Chung-Ang University College of Medicine, Seoul, Republic of Korea

    Background/Purpose: Although gout is accompanied by the substantial burden of kidney disease, there is limited data to assess renal function as a therapeutic target. There…
  • Abstract Number: 335 • 2019 ACR/ARP Annual Meeting

    Renal Transplant Complications in Patients with and Without Gout

    Megan Francis-Sedlak1, Brian LaMoreaux 1 and Robert Holt 1, 1Horizon Therapeutics plc, Lake Forest, IL

    Background/Purpose: Graft-related complications are among the most serious issues solid-organ transplant recipients and their healthcare teams face post-operatively. Gout is a known frequent co-morbidity in…
  • Abstract Number: 336 • 2019 ACR/ARP Annual Meeting

    Treating Gout to Target Entails Renoprotective Effect in Patients with Moderate Chronic Kidney Disease

    enrique Calvo-Aranda1, Marta Novella-Navarro 2, jOSE LUIS CABRERA-ALARCON 3, Francisco Aramburu 2, Iustina Janta 4, Alejandro Prada-Ojeda 5, Luis Sala-Icardo 5, Maria del Carmen Ortega de la O 6, Cesar Diaz-Torne 7 and A. Urruticoechea-Arana 8, 1Hospital Universitario Infanta Leonor, Madrid, Spain, 2Hospital Universitario HM Sanchinarro, madrid, Spain, 3Bioinformatica CNIC, madrid, Spain, 4Hospital General Universitario Gregorio Marañón, madrid, Spain, 5Hospital Universitario de Torrejon, madrid, Spain, 6Hospital Universitario Santa Elena, madrid, Spain, 7Hospital de la Santa Creu i Sant Pau, barcelona, Catalonia, Spain, 8HU Can Misses, Ibiza, Spain

    Background/Purpose: Approximately 25% of patients with gouty arthritis suffer from chronic kidney disease (CKD). High serum uric acid (sUA) levels have been related to glomerular…
  • Abstract Number: 337 • 2019 ACR/ARP Annual Meeting

    Gout in the US: Significant Association with Cardiovascular and Renal Disease Hospitalizations – A Nationwide Study

    Alka Mithal 1, Maanek Sehgal 2 and Gurkirpal Singh1, 1ICORE, Woodside, 2UCLA, Los Angeles

    Background/Purpose: Gout is a disorder of uric acid metabolism and often presents as acute severe joint pain. Previous work from our group suggests that all-cause…
  • Abstract Number: 338 • 2019 ACR/ARP Annual Meeting

    Effect of Serum Urate Lowering with Allopurinol on Blood Pressure in Young Adults

    Angelo Gaffo1, David Calhoun 2, Elizabeth Rahn 1, Suzanne Oparil 2, Peng Li 2, Tanja Dudenbostel 2, David Redden 2, Amy Mudano 2, Jeffrey Foster 1, Daniel Feig 2, Stephanie Biggers 2 and Kenneth Saag 1, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham

    Background/Purpose: The association between serum urate and hypertension continues to be a matter of controversy.  Studies in adolescents provided evidence for the efficacy of urate…
  • Abstract Number: 339 • 2019 ACR/ARP Annual Meeting

    Depressive Symptoms Influence Success of Allopurinol in Reducing Serum Urate

    Sylvie Mrug 1, Catheryn Orihuela 1, Elizabeth Rahn 2, Amy Mudano 1, Kenneth Saag 2, Jeffrey Foster 2 and Angelo Gaffo2, 1University of Alabama at Birmingham, Birmingham, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Elevated levels of serum urate (sUA) are central to the pathogenesis of gout and have been associated with cardiovascular disease. Urate-lowering therapies are effective…
  • Abstract Number: 340 • 2019 ACR/ARP Annual Meeting

    Increased Physical Activity in Gout Patients Correlates with Better Prognosis, Decreased Pain, and Suppressed C-Reactive Protein Levels

    Naomi Schlesinger1, Kyle Jablonski 2, Peter Harb 3, Caitlin Henry 3, Emily Schwarz 3, Ifeoma Okafor 3, Wael Jarjour 4 and Nicholas Young 5, 1Rutgers Health- RWJ Medical School, New Brunswick, NJ, 2The Ohio State University Wexner Medical Center, Division of Immunology and Rheumatology, Columbus, 3Ohio State College of Medicine, Columbus, 4Ohio State College of Medicine, Columbus, OH, 5The Ohio State University Wexner Medical Center, Division of Immunology and Rheumatology, Columbus, OH

    Background/Purpose: Regular exercise programs were previously thought to be inappropriate in patients with rheumatic diseases because of the potential to exacerbate inflammation. However, while recent paradigm-shifting…
  • Abstract Number: 341 • 2019 ACR/ARP Annual Meeting

    Development of a Multivariable Improvement Measure for Gout

    Naomi Schlesinger1, N. Lawrence Edwards 2, Anthony Yeo 3 and Peter Lipsky 4, 1Division of Rheumatology, Department of Medicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, 2Department of Medicine, University of Florida, Gainesville, FL, 3Horizon Therapeutics plc, Lake Forest, IL, 4AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Gout is a multifactorial inflammatory disease in which patients experience a wide range of signs and symptoms, including flares, inflammatory arthritis, tophi and disability.…
  • Abstract Number: 342 • 2019 ACR/ARP Annual Meeting

    Rheumatologist Care Is Associated with Fewer Emergency Room Visits by Persons with Gout

    Naomi Schlesinger1, N. Lawrence Edwards 2, Sanders Clark 3 and Peter Lipsky 4, 1Division of Rheumatology, Department of Medicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, 2Department of Medicine, University of Florida, Gainesville, FL, 3HVH Precision Analytics, LLC, Wayne, PA, 4AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Gout is one of the most common inflammatory arthropathies, although care of gout patients is not always optimal. By searching a large administrative data…
  • Abstract Number: 343 • 2019 ACR/ARP Annual Meeting

    Emergency Department Length of Stay in Patients with Acute Gout

    Nadine Mbuyi1, Steven Reinert 2, Ross Hilliard 3, Anthony Reginato 3 and Deepan Dalal 3, 1George Washington University, Washington, DC, 2Lifespan Health System, Providence, RI, 3Brown University, Rhode Island Hospital, Providence, RI

    Background/Purpose: Emergency department (ED) visits for acute gout increased by approximately 20% between 2006 and 2014 in the United States. (1) Reducing ED length of stay…
  • « Previous Page
  • 1
  • …
  • 1156
  • 1157
  • 1158
  • 1159
  • 1160
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology